08 Aug, EOD - Indian

Nifty 50 24363.3 (-0.95)

SENSEX 79857.79 (-0.95)

Nifty Next 50 65514.7 (-1.24)

Nifty Smallcap 100 17428.2 (-1.49)

Nifty Pharma 21402.15 (-1.30)

Nifty IT 34398.5 (-0.95)

Nifty Bank 55004.9 (-0.93)

Nifty Midcap 100 56002.2 (-1.64)

08 Aug, EOD - Global

NIKKEI 225 41820.48 (1.85)

HANG SENG 24858.82 (-0.89)

S&P 6425.5 (0.74)

LOGIN HERE

companylogoJainex Aamcol Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 505212 | NSE Symbol : | ISIN : INE280F01019 | Industry : Auto Ancillaries |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
19-May-2025 27-May-2025 Accounts Jainex Aamcol Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve Audited Financial Results of the Company for the Financial Year ended 31 2025. Please find standalone audited financial results for the quarter and year ended 31st March 2025 (As Per BSE Announcement Dated on :27.05.2025) PLEASE FIND ATTACHED STANDALONE AUDITED FINANCIAL RESULT FOR THE QUARTER AND YEAR ENDED 31-03-2025 ALONG WITH AUDIT REPORT BY THE STATUTORY AUDITORS ALSO ATTACHED UN MODIFIED OPINION DECLARATION SIGNED BY THE DIRECTOR (As Per BSE Announcement Dated on 28.05.2025)
07-Apr-2025 17-Apr-2025 Raising funds through Debt Instr. Jainex Aamcol Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/04/2025 inter alia to consider and approve various fund-raising options for the Company Jainex Aamcol Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/04/2025 ,inter alia, to consider and approve With reference to our prior intimation dated 07th April 2025 and pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, this is to inform you that the meeting of the Board of Directors of the Company which was scheduled to be held on Friday, April 11, 2025 has been rescheduled due to unavoidable reasons and now it will be held on Thursday 17th April 2025 to inter alia consider and approve various fund-raising options for the Company, in the light of the amendment to the SEBI (ICDR) Regulations, as the Board may deem appropriate. Details of the proposal shall be intimated in the outcome of the meeting. Kindly take the above on record and oblige (As per BSE Announcement Dated on 11/04/2025) Further to our letter dated 11th April, 2025 regarding the intimation of the reschedule of the meeting of the Board of Directors of the Company, in accordance with the provisions of Regulation 30 of the SEBI Listing Regulations, please be informed that the Board of Directors of the Company at its meeting held on April 17, 2025 has, inter alia, considered and approved the raising of funds through issuance and allotment of equity shares of face value of Rs. 10/- each ('Equity Shares') for up to an aggregate amount of up to Rs. 9,00,00,000 (Rupees Nine crores only), on a Rights basis on such terms (as decided by the Board of Directors or a duly constituted committee of the Board of Directors at a later date) to the eligible equity shareholders of the Company, as on the record date (to be notified subsequently). (As Per BSE Announcement dated on 17.04.2025)
01-Apr-2025 01-Apr-2025 Change in Directors It is hereby informed that Mr. Daljeet Singh Saljua and Mr. Prashant Chintaman Wadile is appointed as Non Executive Independent Director and Whole-time Director respectively w.e.f. 01/04/2025.
03-Feb-2025 14-Feb-2025 Quarterly Results JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter and nine-months ended December 31 2024. PLEASE FIND ATTACHED UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER 2025 ALONG WITH LIMITED REVIEW REPORT OF THE AUDITORS (As Per BSE Announcement Dated on 14.02.2025)
03-Dec-2024 09-Dec-2024 Raising funds through Debt Instr. JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2024 inter alia to consider and approve various fund-raising options for the Company as the Board may deem appropriate. Details of the proposal shall be intimated in the outcome of the meeting. Further to our letter dated 03rd December, 2024 regarding the intimation of the meeting of the Board of Directors of the Company, in accordance with the provisions of Regulation 30 of the SEBI Listing Regulations, please be informed that the Board of Directors of the Company at its meeting held on December 09, 2024 has, inter alia, considered and approved the raising of funds through issuance and allotment of equity shares of face value of Rs. 10/- each ('Equity Shares') for up to an aggregate amount of up to Rs. 9,00,00,000 (Rupees Nine crore only), on a Rights basis on such terms (as decided by the Board of Directors or a duly constituted committee of the Board of Directors at a later date). (As per BSE Announcement Dated on 09/12/2024)
04-Nov-2024 25-Nov-2024 Quarterly Results JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter and half year ended September 30 2024 The Board Meeting to be held on 14/11/2024 Stands Cancelled. This meeting had been adjourned and intimation of the new date of Board Meeting will be informed separately. (As Per BSE Announcement Dated on: 13/11/2024) JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/11/2024 ,inter alia, to consider and approve the Un-audited Financial Results of the Company for the quarter and half year ended September 30, 2024 (As Per BSE Announcement Dated on: 18/11/2024) PFA disclosure of reason for delay in unaudited financial Result for the quarter and half year ended 30/09/2024 On being discharged from the hospital, the company had rescheduled the board meeting to be held on 25th November 2024 and accordingly informed the Exchange on 18th November 2024. The approved result was duly filed on Listing Portal on 25th November 2024. (As Per BSE Announcement dated on 27.11.2024)
02-Aug-2024 14-Aug-2024 Quarterly Results JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30 2024. Pursuant to Regulation 30 [read with Part A of Schedule 1.11] and 33 of SEBl (Listing Obligations and Disclosure Requirements) Regulations 20 l5, ('Listing Regulations), we would like to inform you that the Board of Directors of the Company at its Meeting held today, inter-alia, has: l . Approved the Unaudited. Standalone Financial Results for the quarter ended 30th June, 2024 as recommended by the Audit Committee. (As per BSE Announcement dated on 14/08/2024)
16-May-2024 30-May-2024 Accounts JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve 1. the Audited Financial Results of the Company for the quarter and year ended March 31 2024. 2. Consider dividend for the year ended March 31 2024 if any. Further in terms of the Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons as framed by the Company under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 the closure of trading window for dealing in securities of the Company for all Designated Persons and their immediate relatives has commenced from April 01 2024 till 48 hours after declaration of the Audited Financial Results of the Company for the quarter and year ended March 31 2024 is made by the Company to the Stock Exchange. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of the statement containing the Standalone Audited Financial Results of the Company (page no 1-5), for the quarter and year ended 31st March, 2024, which has been approved at the Meeting of the Board of Directors, held today. The Board Meeting commenced at 12.00 p.m. and concluded at 2.15 p.m. We also enclose a copy of Audit Report signed by our Statutory Auditors, M/s R.K.Jagetiya & Company, Chartered Accountants, Mumbai along with a declaration signed by Director of the Company (for Audit Report with Unmodified opinion) . Read less.. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of the statement containing the Standalone Audited Financial Results of the Company (page no.1-5)for the quarter and year ended 31st March 2024, which has been approved at the Meeting of the Board of Directors held today. The Board Meeting commenced at 12.00 p.m. and concluded at 2.15 p.m. We also enclose a copy of Audit Report signed by our Statutory Auditors, M/s.R.K.Jagetiya & Company, Chartered Accountants, Mumbai along with a declaration signed by Director of the Company (for Audit Report with Unmodified opinion (As Per BSE Announcement Dated on 30.05.2024)
30-Jan-2024 13-Feb-2024 Quarterly Results JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (hereinafter referred to as the 'Listing Regulations') we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 13th February 2024 inter-alia to consider and approve the Un-audited Financial Results of the Company for the quarter and nine months ended December 31 2023 Pursuant to Regulation 33 of SEBl (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the following:- (a) Standalone Unaudited Financial Results of the Company, for the Quarter and Nine months period ended 31st December, 2023, which has been approved at the Meeting of the Board of Directors held today along with a copy of the Limited Review Report for the Quarter and Nine months period ended 31st December 2023 issued by our Statutory Auditors, R.K.Jagetiya & co.,Chartered Accountants, Mumbai. The results in the prescribed format will be published in the Newspapers pursuant to Regulation 47(1) (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Meeting of the Board of Directors commended on 11.00 A.M and concluded at 12.15 P.M. This is for your information and records. PURSUANT TO REGULATION 33 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015, WE ARE ENCLOSING HEREWITH THE FOLLOWINGS : (A) STANDALONE UNDAUNTED FINANCIAL RESULTS OF THE COMPANY, FOR THE QUARTER AND NINE MONTHS PERIOD ENDED 31ST DECEMBER, 2023, WHICH HAS BEEN APPROVED AT THE MEETING OF THE BOARD OF DIRECTORS HELD TODAY ALONG WITH A COPY OF THE LIMITED REVIEW REPORT FOR THE QUARTER AND NINE MONTHS PERIOD ENDED 31ST DECEMBER 2023 ISSUED BY OUR STATUTORY AUDITORS R.K. JAGETIYA & CO CHARTERED ACCOUNTANTS MUMBAI. THE RESULTS IN THE PRESCRIBED FORMAT WILL BE PUBLISHED IN THE NEWSPAPER PURSUANT TO REGULATION 47 (1) (B) OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015 (As Per BSE Announcement Dated on 13/02/2024)
01-Nov-2023 08-Nov-2023 Quarterly Results JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (hereinafter referred to as the 'Listing Regulations') we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday 8th November 2023 inter-alia to consider and approve the Un-audited Financial Results of the Company for the quarter and half year ended September 30 2023 Pursuant to regulation 33 of SEBI( Listing Obligation and Disclosure Requirements) Regulation, 2015, we are enclosing herewith Unaudited Financial Result for the quarter and half year ended 30/09/2023 PURSUANT TO REGULATION 33 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015, WE ARE ENCLOSING HEREWITH THE FOLLOWING : (A) UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER/HALF YEAR ENDED 30TH SEPTEMBER, 2023 (B) LIMITED REVIEW REPORT OF THE AUDITORS THE ABOVE RESULTS HAVE BEEN REVIEWED BY THE AUDIT COMMITTEE AND APPROVED BY THE BOARD OF DIRECTORS OF THE COMPANY IN THEIR MEETING HELD ON TODAY, I.E. 8TH NOVEMBER, 2023. THE RESULTS IN THE PRESCRIBED FORMAT WILL BE PUBLISHED IN THE NEWSPAPER PURSUANT TO REGULATION 47(1) (b) OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATION, 2015. THE MEETING OF THE BOARD OF DIRECTORS COMMENDED ON 11.00 A.M. AND CONCLUDED ON 1.45 P.M.. THIS IS FOR YOUR INFORMATION AND RECORDS. (As Per BSE Announcement Dated on 08/11/2023)
25-Jul-2023 02-Aug-2023 Quarterly Results Quarterly Results JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 ,inter alia, to consider and approve Un-audited Financial Results of the Company for the quarter ended June 30, 2023 Pursuant to Regulation 30 and 33 of SEBI Regulation 2015 we would like to inform you that the Board of Directors of the Company at its Meeting held today inter alia has approved the Unaudited Standalone financial results for the quarter ended 30th June 2023 as recommended by the Audit committee. We are enclosing Unaudited standalone financial results for the quarter ended 30th June 2023 along with statutory auditors limited review report thereon. Pursuant to Regulation 30 and 33 of SEBI Regulation 2015 we would like to inform you that the Board of Directors of the Company at its Meeting held today inter alia has approved the Unaudited Standalone financial results for the quarter ended 30th June 2023 as recommended by the Audit committee. We are enclosing Unaudited standalone financial results for the quarter ended 30th June 2023 along with statutory auditors limited review report thereon. (As Per BSE Announcement Dated on 02.08.2023)
18-May-2023 30-May-2023 Accounts JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve 1. The Audited Financial Results of the Company for the quarter and year ended March 31 2023. 2. dividend for the year ended March 31 2023 if any. Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Audited Standalone Results for the quarter and year ended March 31, 2023. In this regard, kindly find enclosed the following: 1. Audited Standalone Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter and year ended March 31, 2023 with an unmodified opinion. 2. The Board has not recommended any dividend for F.Y. 2022-23 The Meeting of the Board of Directors commenced at 12:00 p.m. and concluded at 02:00 p.m. (As Per BSE Announcement Dated on 30.05.2023)
31-Jan-2023 13-Feb-2023 Quarterly Results JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (hereinafter referred to as the 'Listing Regulations') we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday 13th February 2023 inter-alia to consider and approve the Un-audited Financial Results of the Company for the quarter and nine month ended December 31 2022 Pursuant to Regulation 33 of SEBl (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the following:- (a) Standalone Unaudited Financial Results of the Company, for the Quarter and Nine months period ended 31st December, 2022, which has been approved at the Meeting of the Board of Directors held today along with a copy of the Limited Review Report for the Quarter and Nine months period ended 31st December 2022 issued by our Statutory Auditors, M/s R.A.Singh and Associates, Chartered Accountants, Mumbai. The results in the prescribed format will be published in the Newspapers pursuant to Regulation 47(1) (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Meeting of the Board of Directors commended on 11.00 A.M and concluded at _12.10_ P.M. This is for your information and records. (As Per BSE Announcement Dated on 13.02.2023)
28-Oct-2022 11-Nov-2022 Quarterly Results JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (hereinafter referred to as the 'Listing Regulations') we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday 11th November 2022 inter-alia to consider and approve the Un-audited Financial Results of the Company for the quarter and half year ended September 30 2022 Pursuant to Regulation 33 of SEBl (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the following:- (a) Unaudited Standalone Financial Results for the quarter/ half year ended 30 th September, 2022 (b) Limited Review Report of the Auditors. The above results have been reviewed by the Audit committee and approved by the Board of Directors of the Company in their meeting held on today i.e. 11th November, 2022 The results in the prescribed format will be published in the Newspapers pursuant to Regulation 47(1) (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Meeting of the Board of Directors commended on 11.00 A.M and concluded on 12.05 P.M. This is for your information and records. (As Per BSE Announcement dated on 11.11.2022)
28-Jul-2022 12-Aug-2022 Quarterly Results JAINEX AAMCOL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve We wish to inform you that pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) a meeting of the Board of Directors of the Company is scheduled to be held on Friday August 12 2022 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30 2022. Further in terms of the Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons as framed by the Company under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 the trading window close period for dealing in securities of the Company for all Designated Persons and their immediate relatives has commenced from July 01 2022 till 48 hours after declaration of the Un-audited Financial Results of the Company for the quarter ended June 30 2022 is made by the Company to the Stock Exchange. Pursuant to Regulation 30 [read with Part A of Schedule lll] and 33 of SEBl (Listing Obligations and Disclosure Requirements) Regulations 2015, ('Listing Regulations), we would like to inform you that the Board of Directors of the Company at its Meeting held today, inter-alia, has: 1. Approved the Unaudited Standalone Financial Results for the quarter ended 30th June, 2022 as recommended by the Audit Committee. We are pleased to enclose the following: i) Unaudited Standalone Financial Results of the Company for the quarter ended 30th June, 2022 and ii) Statutory Auditors Limited Review Report on Un-audited Financial Results of the Company the quarter ended 30th June, 2022. The Meeting of the Board of Directors commended on 11.00 A.M. and concluded on 12.40 P.M. This is for your information and records (As per BSE Announcement Dated on 12/08/2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +